Data on Information Technology Reported by Thien Le Tri and Colleagues (Potentially inappropriate medications in nursing homes and the community older adults using the French health insurance database): Information Technology

2022 DEC 02 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Information Technology is the subject of a report. According to news originating from Saint-Denis, France, by NewsRx correspondents, research stated, “Potentially Inappropriate Medications (PIMs) have become a major issue in improving prescribing practices and reducing the risk of drug adverse events in older people. However, very few studies have compared exposition to PIMs controlling for differences in demographic and health between Nursing Home Residents (NHRs) and Community-Dwelling Older Adults (CDOAs).”

Our news journalists obtained a quote from the research, “This study aimed to assess the prescribing pattern of PIMs between NHRs and CDOAs. We conducted a cross-sectional study over three months in 2019 using the French health insurance database. The study population included 274,971 NHRs and 4,893,721 CDOAs aged 75 years and older. The Prevalence Ratio (PR) between NHRs and CDOAs of seventeen PIM indicators, based on the Beers and STOPP criteria lists, was assessed using multivariable robust Poisson regression adjusted for age, sex, diseases, and polypharmacy. During the study period, 54% of NHRs and 29% of CDOAs received at least one PIM. After adjustment, the prevalence of PIMs was 33% higher among NHRs compared to CDOAs (aPR=1.33; 95%CI[1.33-1.34]). NHRs received PIMs related to benzodiazepines (aPR=1.43; 95%CI[1.42-1.43]), anticholinergic drugs (aPR=1.29; 95%CI[1.27-1.31]), and at least three central nervous system-active drugs (aPR=1.94; 95%CI[1.92-1.96]) more frequently. Prevalence of PIMs related to non-steroidal anti-inflammatory drugs (aPR=0.50; 95%CI[0.48-0.52]) and long-acting benzodiazepines (aPR=0.84; 95%CI[0.82-0.85]) was lower among NHRs. NHRs were at greater risk for PIM than CDOAs, although differences exist according to the category of PIMs.”

According to the news editors, the research concluded: “As the population is aging, it is essential to promote and evaluate interventions in NHs and in the community to enhance medication optimization.”

This research has been peer-reviewed.

For more information on this research see: Potentially inappropriate medications in nursing homes and the community older adults using the French health insurance database. Pharmacoepidemiology and Drug Safety, 2022. Pharmacoepidemiology and Drug Safety can be contacted at: Wiley, 111 River St, Hoboken 07030-5774, NJ, USA. (Wiley-Blackwell - http://www.wiley.com/; Pharmacoepidemiology and Drug Safety - http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1557)

The news correspondents report that additional information may be obtained from Thien Le Tri, EPI-PHARE, epidemiology of health products (French National Agency for the Safety of Medicines and Health Products and French National Health Insurance), Saint-Denis, France. Additional authors for this research include Solene Drusch, Joel Ankri, Hugues Michelon, Mahmoud Zureik and Marie Herr.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1002/pds.5575. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

The publisher’s contact information for the journal Pharmacoepidemiology and Drug Safety is: Wiley, 111 River St, Hoboken 07030-5774, NJ, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)